Subscribe To
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTon and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTon and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am
Baxter international beats q3 profit estimates on strong demand for medical devices
Baxter International on Thursday beat Wall Street expectations for third-quarter revenue and profit, as...
November 2, 2023, 9:08 am
Ecb's knot: policy rates now are at a good 'cruising altitude'
Current level of rates can remain for some timeShould be a little patient and not raise rates too much to prevent choking off the economyIf even the m...
November 2, 2023, 9:08 am
A bullish storm is brewing for cloud stocks
Results from ServiceNow NASDAQ: NOW bode well for cloud services stocks. The company posted results that sparked a round of surprisingly bullish chatt...
November 2, 2023, 9:05 am
Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition
– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion ...
November 2, 2023, 9:05 am
Electric truck maker nikola reports wider loss in third quarter
Nikola posted a wider loss in the third quarter on Thursday, after the electric truck maker suspended s...
November 2, 2023, 9:03 am
Big tech sell-off: will tesla be the next domino to fall?
Top Nasdaq stocks have undergone steep sell-offs. So far this year, Tesla's results have been worse than expected....
November 2, 2023, 9:03 am
7 value stocks to buy while they are still out of the limelight
Although 2023 has witnessed a massive surge in relevant industries – most notably artificial intelligence – investors may want to consider value s...
November 2, 2023, 9:02 am
A top meta scientist's claims ai won't wipe out humanity are dangerous, says his former co-researcher
AI godfather Yoshua Bengio says the risks of AI should not be underplayed. In an interview with Insider, Bengio criticized peers dismissing AI's t...
November 2, 2023, 9:02 am
Mondelez (mdlz) ups view on q3 earnings beat: organic sales aid
Mondelez's (MDLZ) third-quarter 2023 results reflect strength across categories, brands and geographies. Management raises guidance for 2023....
November 2, 2023, 9:01 am
Scotts miracle-gro (smg) q4 earnings & sales beat estimates
The decline in sales of Scotts Miracle-Gro (SMG) is due to lower sales in the U.S. Consumer and Hawthorne segments in Q4....
November 2, 2023, 9:01 am
Medifast (med) queues for q3 earnings: what awaits the stock?
Medifast's (MED) third-quarter results are likely to reflect concerns surrounding customer acquisition ...
November 2, 2023, 9:01 am
Roku's q3 loss wider than expected, revenues increase y/y
ROKU's third-quarter 2023 results benefit from growing active accounts and streaming hours on The Roku ...
November 2, 2023, 9:01 am
Ansys (anss) q3 earnings beat estimates, revenues fall y/y
ANSYS' (ANSS) third-quarter performance was affected by incremental restrictions for export to China....
November 2, 2023, 9:01 am
New strong sell stocks for november 2nd
EADSY, AMTB and CBRE have been added to the Zacks Rank #5 (Strong Sell) List on November 2, 2023....
November 2, 2023, 9:01 am
Primo (prmw) q3 earnings beat estimates
Primo (PRMW) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings o...
November 2, 2023, 9:01 am
Dorian lpg (lpg) q2 earnings and revenues beat estimates
Dorian LPG (LPG) came out with quarterly earnings of $1.85 per share, beating the Zacks Consensus Estimate of $1.73 per share. This compares to earnin...
November 2, 2023, 9:01 am
Spirit aerosystems (spr) q3 loss narrows, revenues rise y/y
Spirit AeroSystems' (SPR) third-quarter 2023 adjusted loss is narrower than the Zacks Consensus Estimate. Revenues increase by 13% ...
November 2, 2023, 9:01 am
Westlake chemical (wlk) q3 earnings beat estimates
Westlake Chemical (WLK) came out with quarterly earnings of $2.20 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to...
November 2, 2023, 9:01 am